IT202200008537A1 - “Nutraceutical or pharmaceutical composition for cardiovascular health” - Google Patents

“Nutraceutical or pharmaceutical composition for cardiovascular health” Download PDF

Info

Publication number
IT202200008537A1
IT202200008537A1 IT102022000008537A IT202200008537A IT202200008537A1 IT 202200008537 A1 IT202200008537 A1 IT 202200008537A1 IT 102022000008537 A IT102022000008537 A IT 102022000008537A IT 202200008537 A IT202200008537 A IT 202200008537A IT 202200008537 A1 IT202200008537 A1 IT 202200008537A1
Authority
IT
Italy
Prior art keywords
nutraceutical
pharmaceutical composition
cardiovascular health
cardiovascular
health
Prior art date
Application number
IT102022000008537A
Other languages
Italian (it)
Inventor
Maio Umberto Di
Original Assignee
Neilos S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neilos S R L filed Critical Neilos S R L
Priority to IT102022000008537A priority Critical patent/IT202200008537A1/en
Priority to PCT/IB2023/054451 priority patent/WO2023209669A1/en
Publication of IT202200008537A1 publication Critical patent/IT202200008537A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT102022000008537A 2022-04-29 2022-04-29 “Nutraceutical or pharmaceutical composition for cardiovascular health” IT202200008537A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT102022000008537A IT202200008537A1 (en) 2022-04-29 2022-04-29 “Nutraceutical or pharmaceutical composition for cardiovascular health”
PCT/IB2023/054451 WO2023209669A1 (en) 2022-04-29 2023-04-28 Nutraceutical or pharmaceutical composition for cardiovascular health

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102022000008537A IT202200008537A1 (en) 2022-04-29 2022-04-29 “Nutraceutical or pharmaceutical composition for cardiovascular health”

Publications (1)

Publication Number Publication Date
IT202200008537A1 true IT202200008537A1 (en) 2023-10-29

Family

ID=82483174

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102022000008537A IT202200008537A1 (en) 2022-04-29 2022-04-29 “Nutraceutical or pharmaceutical composition for cardiovascular health”

Country Status (2)

Country Link
IT (1) IT202200008537A1 (en)
WO (1) WO2023209669A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006029577A1 (en) * 2004-09-17 2006-03-23 Institute Of Medicinal Biotechnology, Chinese Academy Of Medical Sciences Methods and compositions for the treatment of hyperlipidemia
WO2007113748A1 (en) * 2006-03-30 2007-10-11 Rottapharm S.P.A. Oral formulation with beneficial cardiovascular effects, comprising berberine
WO2020002161A1 (en) * 2018-06-26 2020-01-02 Neilos S.r.l. Composition for the prevention and treatment of cardiovascular diseases
US20200085776A1 (en) * 2018-09-10 2020-03-19 Cardax, Inc. Methods of Reducing C-Reactive Protein and/or Treating Cardiovascular Disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104547432A (en) * 2015-02-02 2015-04-29 吴琼 Traditional Chinese medicine composition for treating hypertensive heart disease and preparation method of traditional Chinese medicine composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006029577A1 (en) * 2004-09-17 2006-03-23 Institute Of Medicinal Biotechnology, Chinese Academy Of Medical Sciences Methods and compositions for the treatment of hyperlipidemia
WO2007113748A1 (en) * 2006-03-30 2007-10-11 Rottapharm S.P.A. Oral formulation with beneficial cardiovascular effects, comprising berberine
WO2020002161A1 (en) * 2018-06-26 2020-01-02 Neilos S.r.l. Composition for the prevention and treatment of cardiovascular diseases
US20200085776A1 (en) * 2018-09-10 2020-03-19 Cardax, Inc. Methods of Reducing C-Reactive Protein and/or Treating Cardiovascular Disease

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
INDER PAL SINGH ET AL: "Berberine and its derivatives: a patent review (2009 – 2012)", EXPERT OPINION ON THERAPEUTIC PATENTS, vol. 23, no. 2, 12 December 2012 (2012-12-12), GB, pages 215 - 231, XP055444683, ISSN: 1354-3776, DOI: 10.1517/13543776.2013.746314 *
LI ZHUO-MING ET AL: "Burge (Danshen): a golden herbal medicine in cardiovascular therapeutics", ACTA PHARMACOLOGICA SINICA, NATURE PUBLISHING GROUP, GB, vol. 39, no. 5, 26 April 2018 (2018-04-26), pages 802 - 824, XP036968666, ISSN: 1671-4083, [retrieved on 20180426], DOI: 10.1038/APS.2017.193 *
ROBERT G. FASSETT ET AL: "Astaxanthin: A Potential Therapeutic Agent in Cardiovascular Disease", MARINE DRUGS, vol. 9, no. 3, 21 March 2011 (2011-03-21), pages 447 - 465, XP055670426, DOI: 10.3390/md9030447 *
RUGA SARA ET AL: "The Activity of Ten Natural Extracts Combined in a Unique Blend to Maintain Cholesterol Homeostasis-In Vitro Model", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 23, no. 7, 1 January 2022 (2022-01-01), pages 3805, XP055982648, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998641/pdf/ijms-23-03805.pdf> DOI: 10.3390/ijms23073805 *
SUADONI MARCO TULLIO ET AL: "Berberine for the treatment of hypertension: A systematic review", COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, ELSEVIER, GB, vol. 42, 24 December 2020 (2020-12-24), XP086468290, ISSN: 1744-3881, [retrieved on 20201224], DOI: 10.1016/J.CTCP.2020.101287 *

Also Published As

Publication number Publication date
WO2023209669A1 (en) 2023-11-02

Similar Documents

Publication Publication Date Title
BRPI0520669A2 (en) pharmaceutical dosage that reduces the effect of food found for atorvastatin administration
BR112012021771A2 (en) methods of using sodium-glucose transporter inhibitors 1 and 2.
CY1123240T1 (en) ANTI-FGF23 ANTIBODY AND A PHARMACEUTICAL COMPOSITION CONTAINING IT
GB202019241D0 (en) Pharmaceutical composition
IT202200008867A1 (en) “Nutraceutical or pharmaceutical composition for cardiovascular health”
IT202200008879A1 (en) “Nutraceutical or pharmaceutical composition for cardiovascular health”
IT202200008534A1 (en) “Nutraceutical or pharmaceutical composition for cardiovascular health”
IT202200008537A1 (en) “Nutraceutical or pharmaceutical composition for cardiovascular health”
EP4122483A4 (en) Oral pharmaceutical composition
DK4153133T3 (en) INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
DK3908321T3 (en) PHARMACEUTICAL COMPOSITION
PT3799864T (en) Essentially sodium-free effervescent solid pharmaceutical compositions
IT201900003841A1 (en) COMPOSITIONS FOR PERSONAL CARE
IT202200004958A1 (en) “Nutraceutical or pharmaceutical composition for renal well-being”
IT202200010583A1 (en) “Nutraceutical or pharmaceutical composition for male infertility”
IT202200010592A1 (en) “Nutraceutical or pharmaceutical composition for male infertility”
IT202200010277A1 (en) “Nutraceutical or pharmaceutical composition for male infertility”
IT202200010280A1 (en) “Nutraceutical or pharmaceutical composition for male infertility”
IT202200010274A1 (en) “Nutraceutical or pharmaceutical composition for male infertility”
IT201900023454A1 (en) RESTORATIVE NUTRACEUTICAL COMPOSITION OF ENERGY METABOLISM
IT202200010271A1 (en) “Nutraceutical or pharmaceutical composition for the prevention and treatment of neuropathies”
CR20220587A (en) PHARMACEUTICAL FORMULATIONS
IT202200003224A1 (en) “Nutraceutical or pharmaceutical composition comprising a fermented red rice extract”
IT201700095631A1 (en) Pharmaceutical composition for the prevention and / or treatment of cardiovascular and osteoarticular pathologies.
ES1306073Y (en) DIETARY SUPPLEMENT